Gabelli Funds LLC Johnson & Johnson Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Gabelli Funds LLC holds 193,035 shares of JNJ stock, worth $28 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

193,035

Previous 194,635 0.82%

Holding current value

$28 Million

Previous $28.4 Million 9.97%

% of portfolio

0.24%

Previous 0.23%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $232,767 - $267,808	-1,600 Reduced 0.82%	193,035 $31.3 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $267,103 - $291,893	-1,850 Reduced 0.94%	194,635 $28.4 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $714,012 - $748,604	-4,600 Reduced 2.29%	196,485 $31.1 Million
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $371,280 - $405,144	2,550 Added 1.28%	201,085 $31.5 Million
Q3 2023 Nov 08, 2023	SELL	$155.75 - $174.48 $228,173 - $255,613	-1,465 Reduced 0.73%	198,535 $30.9 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $779,467 - $838,855	5,050 Added 2.59%	200,000 $33.1 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $226,575 - $270,390	1,500 Added 0.78%	194,950 $30.2 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $897,119 - $1.01 Million	-5,600 Reduced 2.81%	193,450 $34.2 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $188,272 - $209,499	-1,167 Reduced 0.58%	199,050 $32.5 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $260,694 - $288,315	-1,550 Reduced 0.77%	200,217 $35.5 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $1.92 Million - $2.18 Million	-12,150 Reduced 5.68%	201,767 $35.8 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $15,593 - $17,301	100 Added 0.05%	213,917 $36.6 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $895,517 - $995,161	-5,545 Reduced 2.53%	213,817 $34.5 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $854,653 - $916,764	-5,359 Reduced 2.38%	219,362 $36.1 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $1.07 Million - $1.19 Million	6,971 Added 3.2%	224,721 $36.9 Million
Q4 2020 Feb 05, 2021	SELL	$137.11 - $157.38 $68,555 - $78,690	-500 Reduced 0.23%	217,750 $34.3 Million
Q3 2020 Nov 06, 2020	SELL	$140.38 - $153.83 $56,152 - $61,532	-400 Reduced 0.18%	218,250 $32.5 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $161,012 - $194,387	-1,250 Reduced 0.57%	218,650 $30.7 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $88,912 - $123,192	-800 Reduced 0.36%	219,900 $28.8 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $4.4 Million - $5.05 Million	-34,500 Reduced 13.52%	220,700 $32.2 Million
Q3 2019 Nov 01, 2019	SELL	$126.95 - $142.14 $317,375 - $355,349	-2,500 Reduced 0.97%	255,200 $33 Million
Q2 2019 Aug 02, 2019	SELL	$131.15 - $144.24 $2.3 Million - $2.52 Million	-17,500 Reduced 6.36%	257,700 $35.9 Million
Q1 2019 May 02, 2019	SELL	$125.72 - $139.79 $2.51 Million - $2.8 Million	-20,000 Reduced 6.78%	275,200 $38.5 Million
Q4 2018 Jan 30, 2019	SELL	$122.84 - $147.84 $4.84 Million - $5.82 Million	-39,400 Reduced 11.78%	295,200 $38.1 Million
Q3 2018 Nov 02, 2018	SELL	$121.58 - $142.88 $1.85 Million - $2.17 Million	-15,200 Reduced 4.35%	334,600 $46.2 Million
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $1.53 Million - $1.69 Million	-12,800 Reduced 3.53%	349,800 $42.4 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $3.75 Million - $4.44 Million	-30,000 Reduced 7.64%	362,600 $46.5 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $8.88 Million - $9.72 Million	-67,700 Reduced 14.71%	392,600 $54.9 Million
Q3 2017 Nov 01, 2017	BUY	$129.47 - $135.38 $59.6 Million - $62.3 Million	460,300	460,300 $59.8 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $380B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Johnson & Johnson Transaction History